An integrative analysis of Qingfei Paidu Decoction for its anti-HCoV-229E mechanism in cold and damp environment based on the pharmacokinetics, metabolomics and molecular docking technology

被引：11

作者：

Zhang, Yan ^{[1
]}

Gu, Xinru ^{[1
]}

Zhou, Yanyan ^{[1
]}

Si, Nan ^{[1
]}

Gao, Wenya ^{[1
]}

Sun, Bo ^{[1
]}

Sun, Jing ^{[1
]}

Li, Tao ^{[2
]}

Wang, Linna ^{[1
]}

Wei, Xiaolu ^{[1
]}

Guo, Shanshan ^{[1
]}

Cui, Xiaolan ^{[1
]}

Bian, Baolin ^{[1
]}

Wang, Hongjie ^{[1
]}

Wang, Liang ^{[3
]}

Zhao, Haiyu ^{[1
]}

机构：

[1] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100007, Peoples R China

[2] China Acad Chinese Med Sci, Med Expt Ctr, Beijing 100007, Peoples R China

[3] China Resources Sanjiu Med & Pharmaceut Co Ltd, Shenzhen 518110, Peoples R China

来源：

PHYTOMEDICINE | 2023年 / 108卷

基金：

中国国家自然科学基金;

关键词：

Qingfei Paidu Decoction; Pharmacokinetics; Metabolomics; Network pharmacology; HCoV-229E; SARS-COV-2; INFECTIONS; COVID-19;

D O I：

10.1016/j.phymed.2022.154527

中图分类号：

Q94 [植物学];

学科分类号：

071001 ;

摘要：

Background: The novel coronavirus pneumonia (COVID-19) has spread rapidly around the world. As a member against the epidemic, Qingfei Paidu Decoction (QFPDD) has been approved for the treatment of COVID-19 in China. However, its antiviral mechanism was still largely unclear. Purpose: An integrated strategy was used to explore the antiviral mechanisms of QFPDD in cold and damp environment, including pharmacokinetic (PK), network pharmacology, metabolomics and protein verification. Methods: Firstly, the pharmacokinetic study of the prototype absorbed ingredients were analyzed by UHPLC-QqQ-MS. Secondly, the metabolomics analysis of the endogenous constituents was carried out. Based on the aforementioned results, an integrated network was constructed to identify the curative components, crucial endogenous differential metabolites and related pathways. Finally, the validation tests were implemented by molecular docking and western blotting (WB). Results: According to the pharmacokinetic behaviors analysis of 31 components in vivo, the flavonoids presented more longer residence time and higher exposure compared with the other compounds. The efficacy and antiviral mechanism of QFPDD were verified by the poly-pharmacology, metabolomics, molecular docking and WB. For the occurrence of metabolic disorder, the change of amino acid transporters should not be neglected. Afterward, 8 curative compounds, 6 key genes and corresponding metabolic pathways were filtered by compound-reaction-enzyme-gene network. The molecular docking verified that the active ingredients bound to the relevant targets well. Conclusion: In the present study, an in vivo comprehensive pharmacokinetic behaviors of QFPDD was analyzed for the first time. The results illustrated that QFPDD could exhibit immune regulation, anti-infection, anti-inflammation and metabolic disorder to perform a corresponding therapeutic effect. Moreover, our findings highlighted the roles of amino acid transporters in the coronavirus infection situation.

引用

页数：13